Open AccessRhino-Orbito-Cerebral-Mucormycosis During the COVID-19 Second Wave in 2021 – A Preliminary Report from a Single Hospital
Author(s) -
Ritu Arora,
Ruchi Goel,
Samreen Khanam,
Sumit Kumar,
Shalin Shah,
Sumitoj Singh,
Mohit Chhabra,
Ravi Meher,
Nita Khurana,
Tanu Sagar,
Suresh Kumar,
Sandeep Garg,
Jyoti Kumar,
Sonal Saxena,
Rashmi Pant
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s324977
Subject(s) - medicine , ptosis , oculomotor nerve palsy , diplopia , mucormycosis , central retinal artery occlusion , surgery , visual acuity , ophthalmology , pediatrics , pathology , palsy , alternative medicine
To list the clinico-epidemiological profile and possible risk factors of COVID-19 associated rhino-orbital-cerebral mucormycosis (CA-ROCM) patients presenting to a COVID dedicated hospital during the second wave of COVID-19 in India.